Functional Medicine

The Institute for Functional Medicine

Jeffrey Bland, a founder of the Institute for Functional Medicine (IFM), writes that the organization was founded in 1991 on a broader definition of function covering the whole biological system. He says that before the 1990s the word 'functional' in medicine mainly referred to functional somatic syndromes, which were often regarded as psychosomatic and managed with behavioral approaches. This account comes from a founder and reflects the movement's own view of its history.

Growth as a named clinical model

Bland describes the term as now denoting a patient-centered, systems-biology approach that he calls a 'clinical operating system'. A 2022 editorial by the same author frames the model as a way of thinking rather than a fixed set of protocols, and argues that lifestyle, diet and environment shape gene expression through the epigenome. The editorial is advocacy-oriented, and the clinical support it cites is largely observational, retrospective or small.

A 2016 commentary by Patrick Hanaway, medical director of the Cleveland Clinic Center for Functional Medicine and chief medical education officer of the IFM, presents the model as a response to the cost of chronic disease in the United States. It states that randomized trials against standard care were underway at the Cleveland Clinic at that time. The sources reviewed do not trace the center's founding date.

Academic center involvement

Much of the published outcome research on the model comes from the Cleveland Clinic Center for Functional Medicine and its collaborators, including authors who are also affiliated with the IFM. Between 2019 and 2026 the center and its collaborators published cohort studies and a randomized pilot trial. These are described in the Research and Evidence section, together with the disclosures that readers should keep in view.

Function as a process and disease as an endpoint

In the IFM's usage, function is a process that can move both forward and backward, while disease is an endpoint. Bland writes that the unique interaction of a person's genome with environment, diet and lifestyle partly determines the direction of change in function over time, and that the model is concerned less with the name of a disease than with the dynamic processes that produced the dysfunction. This is a conceptual position of the movement and not a measured biomedical construct.

Imbalances, nodal points and the matrix

Sources list the model's organizing categories differently. Hanaway names seven core clinical imbalances: assimilation, defense and repair, energy production, biotransformation, communication, transport and structural integrity. Bland's 2022 editorial lists six physiological processes: assimilation, defense and repair, bioenergetics, transport, communication and structural integrity. Hanaway also refers to a Functional Medicine Matrix Model that organizes these categories, and a cardiology review uses the term 'nodal points' for inflammation, oxidative stress and similar processes.

Distinct from integrative medicine

A 2026 review by integrative medicine physicians says integrative medicine and functional medicine are frequently conflated but are different models. It describes integrative medicine as an academic discipline that works within conventional standards of diagnosis and management, and functional medicine as a distinct clinical model built on the search for individualized root causes through specialized diagnostic constructs and non-standard laboratory testing. The authors take a critical position on the second model, so the contrast is a published viewpoint and not a neutral definition.

Assessment and care planning

Hanaway describes four components of practice: taking the patient's illness narrative, prioritizing modifiable lifestyle factors, organizing imbalances in a systems-biology matrix, and building a partnership between clinician and patient. Treatment is described as moving from foundational nutrition and lifestyle change to prioritized imbalances, with follow-up guided by patient-reported outcomes. Tools named include diet, nutraceuticals and targeted pharmaceuticals.

Visit structure at the Cleveland Clinic center

In a 2019 cohort study, new patients at the Cleveland Clinic Center for Functional Medicine saw a registered dietitian and a health coach as well as a clinician, and could also see a behavioral health therapist. Initial visits involved 60 to 75 minutes of clinician time. The authors note that multidisciplinary teams are not universal across practices that use the label, so this description does not apply to every clinic.

A 2021 study at the same center describes a 10-week functional medicine shared medical appointment (a group visit format) alongside individual appointments. Delivery formats, visit lengths and testing therefore vary between settings, and the sources reviewed do not define a standard protocol.

Interventions in a trial setting

In a Cleveland Clinic pilot trial in type 2 diabetes, the functional medicine arm received physician, nutrition and health coach care in addition to usual endocrinology care. Described elements included symptom-based testing, dietary change such as eliminating foods linked to reactions, a tailored supplement regimen, and lifestyle advice on exercise, stress and sleep. A second phase addressed gut dysbiosis or 'leaky gut' and heavy metal burden where considered indicated. The authors note there was no standardized protocol.

Training and credentials

The IFM offers its own certification program, but its certification pages returned an access error when opened for this draft, so no requirements are stated here. No source reviewed describes a statutory regulation or a protected professional title specific to functional medicine. Sources describe practitioners as clinicians who hold other health professional licenses, and the term is not itself a licensed profession in the material reviewed.

Chronic conditions named by proponents

Proponents present the model mainly for complex chronic conditions. Published articles by authors affiliated with the movement apply it to inflammatory arthritis, type 2 diabetes, atrial fibrillation, obesity and neurodegeneration, among others. A 2007 review proposed that toxins contribute to obesity and treatment resistance and called for further research on detoxification methods, while a 2021 cardiology review argues that diet and lifestyle can address proposed contributors to atrial fibrillation. These are proponent positions and proposed mechanisms, not trial findings.

Claims about reversal and cost

Hanaway states that addressing root causes with lifestyle change can reduce costs and improve value, and Bland writes that dysfunction has potential for reversibility within the model. In the Hanaway commentary the central illustration is a single case with several simultaneous interventions, and the author acknowledges that trials are needed. Statements about reversing illness or reducing system costs are therefore claims, and the studies below test narrower questions.

Cleveland Clinic center cohort evaluations

A 2019 retrospective study compared 7,252 adult patients at the Cleveland Clinic Center for Functional Medicine with patients at a Cleveland Clinic family health center, using propensity-score matching. At 6 months the Global Physical Health score (a patient-reported measure) rose 1.59 points in the functional medicine group against 0.33 in the comparison group in 398 matched pairs (P = .004). At 12 months the groups did not differ significantly. The authors called the results exploratory, noted no adjustment for multiple comparisons, and listed longer visit times and unmeasured patient motivation as possible influences.

A 2020 retrospective study of 54 patients with rheumatoid or psoriatic arthritis found a 0.92-point reduction in pain and a 2.84-point improvement in physical health scores at 12 weeks for a functional medicine program added to standard care, compared with standard care alone. The authors cite the retrospective design and baseline differences between groups as limitations. Only the abstract was read for this draft.

What the delivery-format study compared

A 2021 study of 213 matched pairs compared two ways of delivering functional medicine care at one center: a shared medical appointment and individual visits. Group patients showed a 1.18-point larger improvement in physical health score at 3 months, and the group format cost slightly less per patient to deliver ($1,549 against $1,633), measured from the health system's perspective. Because both arms received functional medicine care, the study does not compare the model with conventional care.

Randomized trials

A Cleveland Clinic open-label pilot trial in insulin-treated type 2 diabetes randomized 71 adults to usual care or usual care plus a functional medicine approach, ending early with 47 completing 12 months. The primary endpoint was met by 15% in the functional medicine arm and 11.1% in the usual care arm (P = 0.68), and glycemic, metabolic and quality-of-life outcomes did not differ significantly. The authors describe it as underpowered and unstandardized, so it cannot show whether the approach has no effect.

A 10-week randomized trial in 125 health care professionals tested an elimination diet with five functional medicine coaching sessions against a self-guided elimination diet. There were no between-group differences in the primary analysis, and both groups improved. A subgroup with more baseline symptoms favored coaching, which is a secondary finding. This trial tested coaching support, not the full model, and several authors are affiliated with the IFM or a coaching academy.

Systematic reviews

A PubMed title search on 2026-10-11 for functional medicine combined with review or randomized trial publication types returned 19 records. Among the records inspected, none was a systematic review of the model as a whole; most were narrative reviews, editorials or condition-specific articles. Other databases were not searched, and the 19 records were not all read, so this is a statement about the search and not proof that no review exists.

Unvalidated frameworks and tests

In a 2012 article, Joseph Pizzorno, who was then vice chair of the IFM board, wrote that the functional medicine model lacks a clear standard and posits multiple individualized diagnostic and therapeutic approaches, most of which have reasonable underlying science but have not been rigorously tested. He wrote that this has led to uncritical acceptance of poorly documented diagnostic procedures and ineffective therapies. The criticism therefore comes from inside the movement.

A 2026 review in The American Journal of Medicine states that many interventions used in the model, including nutrition, exercise, sleep and stress management, are evidence based, but that evidence validating the model as a distinct diagnostic and therapeutic approach remains limited. The authors argue that new clinical frameworks should meet the same evidence and clinical validity standards expected elsewhere in medicine. Only the PubMed abstract was available for this draft.

Cost to patients and the health system

The 2026 review states that functional medicine diagnostic strategies may contribute to low-value testing, care cascades and health inequities through substantial out-of-pocket costs. The Cleveland Clinic cost figure above covers delivery cost to the health system and does not address patient out-of-pocket spending. In the diabetes pilot, the functional medicine arm took more medications at 6 and 12 months, mainly supplements.

Independence of the evidence

Several of the studies above were written by authors with ties to the IFM or to functional medicine practices. Disclosures in the 2019 and 2021 Cleveland Clinic papers include a consulting role for the IFM, a laboratory company fee, a patent and income from nutritional supplement sales. Disclosure does not show that findings are biased, but the evidence base is not independent of the movement, and the critique by integrative physicians also comes from a competing perspective.

Harms reported in studies

The Cleveland Clinic pilot trial did not include dedicated adverse event reporting. Estimated hypoglycemia probability was higher in the functional medicine arm at 12 months (0.52 against 0.32) and 24 months (0.53 against 0.20), with wide confidence intervals and differences that were not statistically significant. The cohort studies reviewed did not report on harms, so the absence of reports should not be read as an absence of harm.

Testing, supplements and multiple medications

Published critique identifies low-value testing and care cascades as a concern of the model's diagnostic approach. A tailored supplement regimen and additional medications were part of the care described in the diabetes trial, which noted that adherence to complex regimens was difficult. The sources reviewed do not give frequencies of supplement-related harms, interactions or test-related false positives, so those cannot be quantified here.

Care boundaries

The model is described by its proponents as applied by licensed clinicians alongside, and not instead of, conventional care. Conditions such as insulin-treated diabetes or inflammatory arthritis were studied as additions to guideline-based treatment. Changing or stopping prescribed medicines, or delaying assessment of new or worsening symptoms, is a matter for the treating clinician. This information is educational and not individualized medical advice.